These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30718867)

  • 1. Fresh from the biotech pipeline-2018.
    Morrison C
    Nat Biotechnol; 2019 Feb; 37(2):118-123. PubMed ID: 30718867
    [No Abstract]   [Full Text] [Related]  

  • 2. Biopharmaceutical benchmarks 2018.
    Walsh G
    Nat Biotechnol; 2018 Dec; 36(12):1136-1145. PubMed ID: 30520869
    [No Abstract]   [Full Text] [Related]  

  • 3. Approval times for supplemental indications for recombinant proteins.
    Gosse ME; Nelson TF
    Nat Biotechnol; 1997 Feb; 15(2):130-4. PubMed ID: 9035135
    [No Abstract]   [Full Text] [Related]  

  • 4. Fresh from the biotech pipeline-2016.
    Morrison C
    Nat Biotechnol; 2017 Feb; 35(2):108-112. PubMed ID: 28135234
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA launches priority vouchers for neglected-disease drugs.
    Waltz E
    Nat Biotechnol; 2008 Dec; 26(12):1315-6. PubMed ID: 19060849
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulators adopt more orphan drugs.
    Reardon S
    Nature; 2014 Apr; 508(7494):16-7. PubMed ID: 24695293
    [No Abstract]   [Full Text] [Related]  

  • 7. Report blames NICE for hastening decline of UK biotech.
    Moran N
    Nat Biotechnol; 2009 Mar; 27(3):215-7. PubMed ID: 19270658
    [No Abstract]   [Full Text] [Related]  

  • 8. Fresh from the biotech pipeline--2013.
    Kling J
    Nat Biotechnol; 2014 Feb; 32(2):121-4. PubMed ID: 24509747
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves licensing of erenumab-aooe to prevent migraine.
    Traynor K
    Am J Health Syst Pharm; 2018 Jul; 75(13):929-930. PubMed ID: 29941531
    [No Abstract]   [Full Text] [Related]  

  • 10. Fresh from the biologic pipeline.
    Osborne R
    Nat Biotechnol; 2009 Mar; 27(3):222-5. PubMed ID: 19270664
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental use and the Orphan Drug Act: a biotechnology conundrum.
    Koivuniemi PJ
    Nat Biotechnol; 1996 Apr; 14(4):511-2. PubMed ID: 9630930
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to biosimilar utilization in the United States.
    Dalpoas SE; Socal M; Proctor C; Shermock KM
    Am J Health Syst Pharm; 2020 Nov; 77(23):2006-2014. PubMed ID: 33091103
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibody: the corner stone of modern biotherapeutics.
    Xia ZN; Cai XT; Cao P
    Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1999 a disappointing year for biotech approvals.
    Piascik P
    J Am Pharm Assoc (Wash); 2000; 40(2):269-70. PubMed ID: 10730031
    [No Abstract]   [Full Text] [Related]  

  • 16. The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States.
    Nakayama H; Matsumaru N; Tsukamoto K
    Invest New Drugs; 2019 Oct; 37(5):1086-1093. PubMed ID: 29855823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies.
    Li J; Florian J; Campbell E; Schrieber SJ; Bai JPF; Weaver JL; Hyland PL; Thway TM; Matta MK; Lankapalli RH; Narayanasamy S; Dancy J; Zusterzeel R; Tyson JY; Prentice KW; Jackson KC; Patel V; Rouse RL; Wang YC; Strauss DG
    Clin Pharmacol Ther; 2020 Jan; 107(1):40-42. PubMed ID: 31667825
    [No Abstract]   [Full Text] [Related]  

  • 18. First US biosimilar edges towards market.
    Senior M
    Nat Biotechnol; 2015 Mar; 33(3):222-3. PubMed ID: 25748898
    [No Abstract]   [Full Text] [Related]  

  • 19. Fresh from the biotech pipeline-2014.
    Morrison C
    Nat Biotechnol; 2015 Feb; 33(2):125-8. PubMed ID: 25658270
    [No Abstract]   [Full Text] [Related]  

  • 20. Erenumab: First Global Approval.
    Markham A
    Drugs; 2018 Jul; 78(11):1157-1161. PubMed ID: 29968151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.